Next Article in Journal
From Pixels to Diagnosis: Algorithmic Analysis of Clinical Oral Photos for Early Detection of Oral Squamous Cell Carcinoma
Previous Article in Journal
Supportive Care Needs of Newly Diagnosed Cancer Patients in a Comprehensive Cancer Center: Identifying Care Profiles and Future Perspectives
Previous Article in Special Issue
The Molecular Mechanisms Underlying Onset and Progression of Liver Cancers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 5
10.3390/cancers16051018
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2021, 13(14), 3475.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Liu et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475

by
Xiaoming Liu
1,2,
Xingyu Chen
1,
Mengqing Xiao
1,
Yuxing Zhu
1,
Renjie Gong
2,
Jianye Liu
3,
Qinghai Zeng
4,
Canxia Xu
2,
Xiong Chen
2,
Fen Wang
2 and
Ke Cao
1,*
1
Department of Oncology, Third Xiangya Hospital of Central South University, Changsha 410013, China
2
Department of Gastroenterology, Third Xiangya Hospital of Central South University, Changsha 410013, China
3
Department of Urology, Third Xiangya Hospital of Central South University, Changsha 410013, China
4
Department of Dermatology, Third Xiangya Hospital of Central South University, Changsha 410013, China
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(5), 1018; https://doi.org/10.3390/cancers16051018
Submission received: 22 December 2023 / Accepted: 10 January 2024 / Published: 29 February 2024
(This article belongs to the Special Issue Molecular Mechanisms Underlying Tumor Onset and Progression in Liver Cancers)
Browse Figures
Versions Notes
In the original publication [1], there was a mistake in Figure 6 as published. We mistakenly exported the wrong IHC results for the “Caspase-3 in HepG2 cell line” shown in Figure 6B. The corrected Figure 6 appears below.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Liu, X.; Chen, X.; Xiao, M.; Zhu, Y.; Gong, R.; Liu, J.; Zeng, Q.; Xu, C.; Chen, X.; Wang, F.; et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475. [Google Scholar] [CrossRef] [PubMed]
Cancers 16 01018 g006aCancers 16 01018 g006b
Figure 6. RANBP2 triggers HCC tumorigenicity via the CEBPα-associated imbalance of O-glycosylation homeostasis in vivo. (A) Silencing of RANBP2 retarded HCC tumor growth, which was effectively counteracted by CEBPα depletion. The sizes of Hep3B and HepG2 tumors formed in the mice with subcutaneous implantation were monitored every three days. Data are presented as the mean ± SD values (n = 6). sh-RANBP2+sh-CEBPα group: * vs sh-RANBP2, ** p < 0.01; # vs NC, # p < 0.05, ## p < 0.01 (t-test). (B) HCC tumorigenicity was confirmed by the immunohistochemical staining of the isolated subcutaneous tumor tissue. sh-RANBP2 significantly decreased the proliferating marker Ki-67, while it increased the apoptosis marker caspase-3. sh-CEBPα was demonstrated to have opposite effects. Scale bars, 20 mm. (C,D) Downstream effectors of RANBP2 and CEBPα related to O-GlcNAc modification and tumor promoter PGC1α were tested by immunoblotting (C) and co-immunoprecipitation (D) in xenograft models.
Figure 6. RANBP2 triggers HCC tumorigenicity via the CEBPα-associated imbalance of O-glycosylation homeostasis in vivo. (A) Silencing of RANBP2 retarded HCC tumor growth, which was effectively counteracted by CEBPα depletion. The sizes of Hep3B and HepG2 tumors formed in the mice with subcutaneous implantation were monitored every three days. Data are presented as the mean ± SD values (n = 6). sh-RANBP2+sh-CEBPα group: * vs sh-RANBP2, ** p < 0.01; # vs NC, # p < 0.05, ## p < 0.01 (t-test). (B) HCC tumorigenicity was confirmed by the immunohistochemical staining of the isolated subcutaneous tumor tissue. sh-RANBP2 significantly decreased the proliferating marker Ki-67, while it increased the apoptosis marker caspase-3. sh-CEBPα was demonstrated to have opposite effects. Scale bars, 20 mm. (C,D) Downstream effectors of RANBP2 and CEBPα related to O-GlcNAc modification and tumor promoter PGC1α were tested by immunoblotting (C) and co-immunoprecipitation (D) in xenograft models.
Cancers 16 01018 g006aCancers 16 01018 g006b
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Liu, X.; Chen, X.; Xiao, M.; Zhu, Y.; Gong, R.; Liu, J.; Zeng, Q.; Xu, C.; Chen, X.; Wang, F.; et al. Correction: Liu et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475. Cancers 2024, 16, 1018. https://doi.org/10.3390/cancers16051018

AMA Style

Liu X, Chen X, Xiao M, Zhu Y, Gong R, Liu J, Zeng Q, Xu C, Chen X, Wang F, et al. Correction: Liu et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475. Cancers. 2024; 16(5):1018. https://doi.org/10.3390/cancers16051018

Chicago/Turabian Style

Liu, Xiaoming, Xingyu Chen, Mengqing Xiao, Yuxing Zhu, Renjie Gong, Jianye Liu, Qinghai Zeng, Canxia Xu, Xiong Chen, Fen Wang, and et al. 2024. "Correction: Liu et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475" Cancers 16, no. 5: 1018. https://doi.org/10.3390/cancers16051018

APA Style

Liu, X., Chen, X., Xiao, M., Zhu, Y., Gong, R., Liu, J., Zeng, Q., Xu, C., Chen, X., Wang, F., & Cao, K. (2024). Correction: Liu et al. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes. Cancers 2021, 13, 3475. Cancers, 16(5), 1018. https://doi.org/10.3390/cancers16051018

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop